INTRODUCTION:

The woody, evergreen shrub Withania somnifera (W. somnifera) is typically referred to as "Winter cherry" or "Indian ginseng" in English, "Ashwagandha" in Sanskrit, "Asgandh" in Hindi, and "Asgand" in Urdu. Its height ranges from 0.5 to 2.0 minutes.

The plant, which is grown in hot, arid regions in tropical and subtropical regions worldwide, is a member of the Solanaceae family. It spreads to warmer regions of Europe and Australia from the Canary Islands, South Africa, the Middle East, Sri Lanka, China, and India (Purdie et al. 1982; Hepper 1991). For more than 5,000 years, the Indian medical systems of Ayurveda and Unani have employed the whole plant or specific portions of W. somnifera for therapeutic and medicinal purposes¹. Additionally, it is stated in the Indian Pharmacopoeia-1985 as an official drug. It is regarded as a significant herbal rasayana and is called "Sattvic Kapha Rasayana." Rasayanas are herbal or metallic preparations used for a variety of pharmacologic properties, including aphrodisiac, adaptogenic, diuretic, anti-helminthic, astringent, tonic, narcotic, immuno-stimulation, anti-inflammation, anti-stress, anti-ulcer, rejuvenative, rheumatism, goitre, boils, pimples, piles, flatulent colic, oligospermia, health promoter, leucoderma, constipation, insomnia, nervous breakdown, and scorpion stings. Additionally, W. somnifera is used for the removal of white spots from the cornea and is also used in anxiety, hysteria, syncope, and memory loss. As a result of its unique ability to reduce stress, this plant species is known as somnifera, or "sleep-inducer."

Since "ashwa" means horse and "gandha" means smell, the plant is named after the characteristic scent of a wet horse found in its roots. Additionally, because of its traditional applications and similar pharmacology to Korean ginseng tea, it is also known as Indian ginseng. Because the phytoconstituents in the plant break down quickly, the pharmacologic activity of the plant lasts for less than two years². Due to this issue, each year between January and March, fresh roots are gathered, and shade drying is done to improve yield and therapeutic outcomes. While leaves are used to treat fever, flowers have diuretic, astringent, depurative, and aphrodisiac qualities. The seeds are anti-helminthic, increase testicular growth and sperm count, and eliminate white spots from the eye, among other medical benefits. Nonetheless, fruits are frequently used to treat many kinds of skin conditions, carbuncles, and ulcers. The distinct pharmacological actions in vitro and in vivo³.

Fig.1 Withania somnifera plant.

Asthma has been treated using a root bark infusion; this application is also typical of Indian traditional herbal remedies. Its root is used as an anti-inflammatory medication for swellings, tumours, and rheumatism in Ayurvedic medicine. It is also used as a sedative and hypnotic for anxiety neurosis. Leaf has hepatoprotective, antimicrobial, and anti-inflammatory qualities. Seeds and fruits contain diuretics. When producing cheese, the berries are used to coagulate milk instead of rennet. Research has demonstrated that the Withania extract's activity was roughly equivalent to that of the Panax ginseng extract. But Withania somnifera appears to prevent ginseng misuse syndrome, which is typified by elevated blood pressure, water retention, tense muscles, and insomnia. This gives it an advantage over Panax ginseng⁴.

PLANT PROFILE:

Kingdom: Plantae, Plants;

Subkingdom: Trophobionta, Vascular plants;

Super Division: Spermatophyta, Seeds plants;

Division: Angiosperma;

Class: Dicotyledons;

Order: Tubiflorae;

Family: Solanaceae;

Genus: Withania;

Species: Somnifera Dunal;

Fig.2-Withania somnifera powder

Benefits of Withania somnifera:

· Supports a healthy immune system.

· Calms mental processes.

· Fosters healthy sleep patterns.

· Benefits a healthy reproductive system in both males and females.

· Supports sustained energy levels, strength, and vitality, including with physical activity.

· Supports a healthy back and joints.

· Supports healthy muscles.

· Promotes thyroid health.

· Promotes healthy functioning of the adrenals⁵.

Properties of Withania somnifera:

The potential properties of Withania somnifera are:

· It might be help with pain relief and sleep

· It may act as a diuretic (expelling urine from the body)

· It may act as an astringent (constricting body tissues)

· It may be an antihelminthic (acting against parasitic worms)

· It may be thermogenic (heat-producing).

· It might have anti-inflammatory (reduces swelling) potential

· It may be an anti-pyretic (reducing fever)

· It may have depurative (detoxifying) properties.

· It may be heart-protective

· It might act as a sedative (inducing sleep)

· It may be thyroprotective (protecting the thyroid gland)

· It might have hypoglycemic (blood sugar lowering) property⁶.

CHEMISTRY:

It is reasonable to be sceptical of Withania somnifera given that many of its claimed benefits have not been scientifically proven, especially given that the herb is said to be effective for a wide range of conditions. WS (Withania somnifera) belongs to a class of herbs called adaptogens or vitalizers in Ayurvedic medicine. Adaptogens appear to induce a state of nonspecific enhanced resistance (SNIR) to deleterious effects of physical, chemical, and biological stimuli. They also cause adaptive reactions to sickness and are helpful in many unrelated conditions. They are generally plant glycosides or alkaloids, normalise pathogenic consequences, are relatively benign, and lack a known precise mechanism of action. Alkaloids, steroids, terpenoids, and other phytochemicals that have long been used in food and traditional medicine are abundant in plants. With the extraction of withaniol, somnirol, somnitol, withanic acid, phytosterol, ipuranol, and alkaloids from alcoholic extracts of leaves and roots, Power and Salway began phytochemical research of W. somnifera in 1911. The alkaloids that were identified as somniferine, somnine, somniferinine, withamine, withanmine, pseudowithamine, and withanaminine were isolated in the investigation. It was found that the plant's alcoholic extract includes several phytochemicals, including cuscohygrine, anahygrine, pseudotropine, choline, dl-isopelletierine, and anaferine. Moreover, withasomnine, a pyrazole alkaloid, was isolated from the W. somnifera alcoholic root extract. It was reported in 1980 that a methanolic extract of the plant leaves contained tisopelletierine, 3α-tigloyloxtropine, cuscohygrine, 3-tropyltigloate, hygrine, dl-isopelletierine, withasomnine, mesoanaferine, withanine, somniferine, hentriacontane, withananine, visamine, ashwagandhine, and pseudowithanine. In addition, it was discovered that the plant's methanolic extract included amino acids like aspartic acid, proline, tyrosine, glycine, glutamic acid, cysteine, and tryptophan as well as reducing sugars, acylsteryl glucosides, ducitol, starch, hantreacotane, and iron. From a methanolic extract of the plant root, seven novel withanosides I–VII were isolated, and structures were verified by UV-visible spectroscopy, 13C and 1H nuclear magnetic resonance (NMR), and Fast Atom Bombardment-Mass Spectrometry.

The steroidal lactones known as withanolides were present in the methanolic extract. Except for the hydroxyl group at C-20 rather than C-27, withanolide D, which was isolated from the alcoholic extract of leaves, showed structural similarities to withaferin A. The 22-hydroxyergostane-26-oic-26, 22-olide with novel structural variants at a carboxylic skeleton or side chains is withanolides, which make up 0.001-0.5% of the total dry weight of leaves and roots. Depending on where they were found, W. somnifera had distinct chemotypes with varying concentrations of substituted steroidal lactones. Chemo-genetic differences in W. somnifera resulted in the presence of 4β, 27-dihydroxy-5β,6β-epoxy-1-oxowitha-2,24-dienolide skeleton in chemotype I, whereas chemotype II had high amounts of withanolide D. Chemotype II, which included a structural alteration at C-20 with a hydroxyl group at 4β and an epoxy system at 5 and 6β positions, was the main one where withanolide D was found. Withanolides E and J, in contrast to other withanolides, had an OH group at C-17 rather than C-20, according to structural characterisation⁷. While withanolides G and J had normal side chain β-orientation, withanolides E and F had α-orientation. Each chemotype's substituted steroidal lactones were derived from genetic variants, and a thorough analysis of the chemotypes revealed differing steroidal contents. (Fig.3)

Fig.3-Withaferin A

HISTORICAL BACKGROUND OF WITHANIA SOMNIFERA:

The ancient medicinal plant Withania somnifera, sometimes referred to as Withania somnifera, has a long and illustrious history that dates back thousands of years. It is mostly indigenous to India, where it has long been used as a crucial component of Ayurvedic therapy. Here is a synopsis of Withania somnifera's history:

1. Ancients Ayurvedic use: Ashwagandha, often known as Withania somnifera, is an age-old remedy with a distinguished past that goes back thousands of years. It is mostly native to India, where it has been used for a very long time as an essential part of Ayurvedic medicine. It is used to support general well-being and has long been advocated for a variety of health problems, such as stress, anxiety, exhaustion, and boosting energy.

2. Historical Documentation: Ancient Ayurvedic scriptures like the "Charaka Samhita" and the "Sushruta Samhita," which contain thorough accounts of its therapeutic benefits, mention the usage of Withania somnifera. It was frequently referred to as "Rasayana," a chemical that encourages vigour and renewal.

3. Historical References: Sanskrit is the origin of the term Ashwagandha, where "Ashwa" means "horse" and "Gandha" means "smell." This term implies that the plant is thought to promote equine power and energy⁸.

4. Medieval and Modern Use: In India and other regions of South Asia, Withania somnifera has been utilised for ages. Other parts of the world have also become familiar with it as a therapeutic herb. It has gained popularity in the West in recent years as a natural treatment for stress, anxiety, and general wellbeing.

5. Scientific Studies: Modern scientific study has been done over the last few decades to investigate Withania somnifera's possible health advantages. Studies have looked at how it affects several medical disorders, including inflammation, stress, and anxiety. According to certain research, Withania somnifera may have adaptogenic qualities that aid in creating equilibrium and assisting the body in adjusting to stress⁹.

BIOACTIVE CONSTITUTES OF WITHANIA SOMNIFERA:

The bioactive substances are found in the plant's leaves, roots, fruits, and stem bark, according to the phytochemical profile of the specimen. While the roots of the plant include alkaloids, steroids, volatile oils, and reducing sugars, the leaves are said to contain 12 withanolides, condensed tannins, flavonoids, glycosides, and free amino acids¹⁰. Due of the compounds' multifaceted relevance, which was previously indicated, there has been a lot of research interest in them. The primary chemical components of WS have been identified as bioactive steroidal lactones, namely withanolides. The withanolides are a class of C-28 steroidal lactones that have a six-membered lactone ring and an ergostane-like structure¹¹. Withanone, withaferin A, and withanolide (A-D) are a few examples of structural variants of withanolides that have been identified and characterised as having biological activity. Wothanolide glycosides, also known as glycowithanolides or withanosides, are present in the plant¹. The plant's methanolic extract includes withanolide alkaloids, glycowithanolides, tropine, choline, pseudotropine, withasomnine, mesoanaferine, withanine, somniferine, hentriacontane, withananine, visamine, ashwagandhine, pseudowithanine, withaniol, reducing sugars, iron, and amino acids like aspartic acid, proline¹².

BIOLOGICAL ACTIVITIES OF WITHANIA SOMNIFERA:

1. Antioxidant Effect of Withinia somnifera:

Due to their high lipid and iron content—both of which are known to play a significant role in the production of reactive oxygen species—the brain and nervous system are comparatively more vulnerable to free radical damage than other tissues.

Fig.4 Biological activities of Withania somnifera

Normal ageing and neurodegenerative illnesses, such as epilepsy, schizophrenia, Parkinson's, Alzheimer's, and other conditions, may be caused by free radical damage to neural tissue. The main enzymes that scavenge free radicals, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX), have been used to measure the antioxidant activity of the active principles of WS, sitoindosides VII–X and withaferin A (glycowithanolides), in the rat frontal cortex and striatum¹³. Degenerative effects arise from the build-up of damaging oxidative free radicals caused by decreased activity of these enzymes. A rise in these enzymes would indicate a protective effect on neural tissue as well as an increase in antioxidant activity. When WS's active glycowithanolides were administered once daily for 21 days, dose-related increases in every enzyme were noted; these increases were like those reported after administering the recognised antioxidant deprenyl. This suggests that WS has an antioxidant impact in the brain, which could account for its many pharmacological characteristics⁹. In a different investigation, the impact of an aqueous suspension of WS root extract on stress-induced lipid peroxidation (LPO) in mice and rabbits was assessed. Peptidoglycans (PGN) from Staphylococcus aureus and lipopolysaccharides (LPS) from Klebsiella pneumoniae both raised the levels of LPO in the blood. Oral WS extract administered concurrently inhibited a rise in LPO. The serum enzymes alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase were evaluated as indicators of hepatotoxicity in addition to hepatic lipid peroxidation (LPO). For comparison, silymarin (20 mg/kg, p.o.) was employed. Iron overload caused a significant rise in the levels of the enzymes in the serum and hepatic LPO, which was reduced by silymarin and glycowithanolides (WSG) in a dose-related manner¹⁴.

2. Antidiabetic effects of Withania somnifera:

The anti-diabetic benefits of Withania somnifera are also taken into consideration when using it. There aren't many reports about this problem, though. In an intriguing review report, Durg et al. detailed the raw material's antidiabetic qualities. The preclinical studies yielded encouraging outcomes. Studies on animals have demonstrated its capacity to reduce blood glucose levels. Furthermore, Tekula et al. verified that Withaferin A has substantial therapeutic promise since it can effectively regulate type 1 diabetes in rats that has been produced by modulating Nrf2/NFκB signalling¹⁵. Molecular docking has also been used in in silico research to validate the potential of withaferin A. Only one clinical research, conducted in 2000, shown a direct reduction in blood glucose levels. However, several studies have indicated a positive impact on the lipidemic profile. In a study using white albino rats that had high cholesterol, it was found that both the antioxidant properties of Withania somnifera and the cholesterol levels decreased¹⁶. In a study by Agnihotri et al., intriguing outcomes were obtained in changing the lipidemic profile, body weight, and blood pressure in the context of clinical trials on diabetes, but not demonstrating an effect on blood sugar levels. Using the DDS17 scale to gauge patients' discomfort, Nayak et al. demonstrated improvements in the lipidemic profile and patient assessment. According to Usharani et al., administering a standardised Withania somnifera extract under the brand name SENSORIL enhanced the lipidemic profile and antioxidant parameters while also proving the raw material's safety and tolerability. Despite its safety and acceptability, Usharani et al. showed that it had an impact on the lipidemic profile and altered the reflection index (RI)¹⁷.

3. Anti-inflammatory effects of Withania somnifera:

Withania somnifera is being researched for the treatment of several inflammatory illnesses, including diabetes, cancer, neurodegenerative diseases, pulmonary, cardiovascular, and autoimmune disorders. Preclinical research has shown that this plant inhibits inflammatory indicators such cytokines (like TNF-a and IL-6), nitric oxide, and reactive oxygen species, which in turn reduces inflammation and regulates mitochondrial activity and apoptosis. Meanwhile, Withania somnifera root powder's possible inhibitory action in lupus-ridden mice was shown in cases of proteinuria and nephritis. Research is also being done on the effectiveness of Withania somnifera in treating rheumatoid arthritis. Rats in research using an animal model were given Withania somnifera root powder orally for three days, one hour prior to the injection of CFA (complete Freund's adjuvant), which caused inflammation. Rats in the control group received phenylbutazone injections. Along with a marked decrease in inflammation, many blood protein concentrations were seen to change, including prealbumin, acute phase protein α1, and α2 glycoprotein. An aqueous solution from Withania somnifera root was found to inhibit the NF-κB and MAPK (mitogen-activated protein kinase) pathways by increasing the expression of anti-inflammatory cytokines and decreasing the expression of pro-inflammatory cytokines, such as interleukin (IL)-8, IL-6, tumor necrosis factor (TNF-α), IL-1β, and IL-12, in a study using the HaCaT human keratinocyte cell line. Considering these findings, it is possible to employ Withania somnifera's anti-inflammatory properties to help avoid skin irritation¹⁸. Withania somnifera water extract (ASH-WEX) was found to have anti-neuroinflammatory effects against lipopolysaccharide-induced systemic neuroinflammation. In a preclinical study, animals treated with ASH-WEX showed reduced expression of nitro-oxidative stress enzymes, inflammatory cytokines like TNF-α, IL-1β, and IL-6, and inhibition of reactive gliosis. The underlying molecular processes behind ASH-WEX's anti-inflammatory properties seem to entail blocking the NFκB, P38, and JNK/SAPK MAPK pathways that are triggered by lipopolysaccharide (LPS). The study's findings point to the possible application of Withania somnifera in reducing inflammation of the nervous system, which is linked to a few neurological conditions. Evidence from research by Kanjilal et al. suggested that people with arthritis may benefit from using Withania somnifera extract for eight to twelve weeks. A study on the impact of Withania somnifera root powder on the activation of immunological activity in immunodeficient mice validated the immunomodulatory effect. It was discovered that giving Withania somnifera increased the quantity of bone marrow and white blood cells overall, as well as the titre of circulating antibodies and antibody-producing cells. It also increased the synthesis of immune cells and the phagocytosis of macrophages. An open-label extension was carried out in a randomized, double-blind, placebo-controlled experiment to assess the impact of Withania somnifera extract on the immune system in healthy individuals. The study's findings demonstrated that, in comparison to a placebo, Withania somnifera extract dramatically raised cytokine levels and natural killer cell activity¹⁹.

4. Anticancer effect of Withania somnifera:

Cancer is defined as group of diseases in which cell growth or division is in uncontrolled manner and is caused by mutations in proteins that encode genes that are involved in the cell cycle, such as anti- and proto-oncogenes. Cancer is a significant, rapidly expanding health and societal issue, according to statistics. Even with international research efforts, cancer is still a leading cause of mortality.

Research has indicated that several chemicals that have been extracted from the root, stem, and leaves of Withania somnifera have anti-cancer qualities. As a result, they can be used either by themselves or in conjunction with other chemotherapeutic drugs to treat cancer. The plant contains alkaloids called witanolides, which have strong anti-cancer properties. Given their significant involvement in apoptosis induction, they are also the most promising molecules exhibiting this effect²⁰. Blood malignancies as well as tumours of the breast, colon, lung, and prostate can be successfully treated with Withania somnifera. It functions as a chemotherapeutic drug against a variety of breast cancer subtypes, particularly triple-negative and ER/PR-positive forms. It exhibits characteristics that not only treat it but also shield against it. Additionally, studies point to Withania somnifera's ability to enhance breast cancer patients' quality of life. Research indicates that Withania somnifera-derived withaferin A is also useful in the management of melanoma. This substance slows the migration of melanoma cells, lowers cell proliferation, and triggers apoptosis. Investigated were withaferin A's anticancer mechanisms in glioblastoma multiforme (GBM). The signalling pathways impacted by withaferin A were identified using RNA-seq analysis, Western blot, immunofluorescence labelling, qRT-PCR, and siRNA gene silencing. In vitro and in vivo, it markedly suppressed GBM development and induced intrinsic death in GBM cells. It did this by defosphorylating Thr161 CDK1, which stopped GBM cells in the G2/M phase of the cell cycle. This discovery holds significance for enhancing regimens based on withaferin A intended for the prophylaxis and/or management of glioblastoma multiforme²¹. According to research by Jawarneh et al., intermittent fasting combined with Withania somnifera extract has the potential to be a successful breast cancer treatment when used in conjunction with cisplatin. The combination was reported to reduce cisplatin-induced toxicity in the liver and kidney, as well as to inhibit the growth of cancer cells by inducing apoptosis. According to Azab et al., the extract reduced oxidative stress and inflammation in the tissues of the liver and spleen, protecting against the negative effects of radiation exposure. According to these results, Withania somnifera root extract may have therapeutic uses in preventing radiotherapy-induced harm to critical organs including the liver and spleen²².

5. Anti-Stress Effects of Withania somnifera:

The physiologic reaction of the body to either internal or external stimuli is known as stress. The type, frequency, and duration of stress all influence the stress response, which is the compensatory mechanism that results from it. Stress has been shown to be a factor that disturbs homeostasis and can both induce and exacerbate a wide range of diseases' symptoms. Individuals who experience continuous pressure, whether at work or at home, and who consequently experience extreme stress, are significantly more prone to numerous illnesses.

Anxiety disorders are the most prevalent psychiatric issues in the general population. Regrettably, because of their chronic nature and the need to take numerous drugs frequently, some patients stop taking their prescriptions, which can result in relapses. The appearance of several adverse effects—which are frequently unavoidable with traditional therapy—is mentioned as a factor in drug discontinuation. This is one of the main reasons it's critical to look for novel treatments with fewer undesirable side effects. A group of patients with a diagnosis of generalised anxiety disorder (GAD) participated in one study. For six weeks, participants received treatment with selective serotonin reuptake inhibitors (SSRIs) in addition to taking one capsule of Withania somnifera extract daily. Following the trial, it was determined that Withania somnifera extract might help individuals with GAD syndrome receiving SSRI medication²³.

Additionally, it was shown that supplementing with Withania somnifera considerably and statistically lowered the HAM-A (Hamilton Anxiety Rating Scale) and, to a lesser degree, the DASS-21 (Depression, Anxiety and Stress Scale). There was also a decrease in DHEA-S and morning cortisol levels. There was a rise in testosterone levels in men. The levels of testosterone in women remained unchanged. The perceived stress scale (PSS) values showed a noteworthy decline. The anxiolytic benefits of Withania somnifera may stem from several processes. First off, Withania somnifera may lessen the hypothalamic-pituitary-adrenal (HPA) axis's activity. The HPA axis indirectly raises the concentrations of cortisol and DHEA in response to a stressor. Dehydroepiandrosterone, or DHEA, is a steroid hormone that is included in the group of hormones known as the "hormones of youth" together with growth hormone and melatonin because their release declines noticeably with age. Between the ages of 20 and 30, DHEA concentrations are at their peak. Many psycho-physical and psychosexual issues are brought on by reduced levels of DHEA in both men and women going through menopause. Furthermore, DHEA controls the concentration of sex hormones by acting as a precursor to them. Research has indicated that the therapy of sexual dysfunction during menopause and andropause may benefit greatly from the administration of DHEA to both sexes. It is commonly recognised that stress and cortisol levels are correlated. It is less common to report the connection between stress and DHEA, though. Excessive increases in DHEA concentrations suggest increased exposure to stress or overactivity of the HPA axis, even though DHEA is linked to health and lifespan. It has been noted that persons experiencing severe stress and those who have gone through traumatic experiences secrete more DHEA²⁴. In middle-aged men, higher DHEA levels are also linked to alcohol and cigarette intake. The anti-inflammatory and antioxidant properties of Withania somnifera are linked to its anxiolytic effects. Inflammatory and oxidative processes are heightened in situations involving stress, depression, and anxiety²⁵. Withania somnifera works on multiple mechanisms at once to block the activities. Even though they are mentioned separately, Withania somnifera's effectiveness rests in their interaction, which is what lifts depressed people's spirits. A sustained-release capsule containing 300 mg of Prolanza TM brand Withania somnifera root extract was used in a study. For ninety days in a row, the participants took one Withania somnifera capsule every day. Treatment with one capsule of Withania somnifera taken once day was found to considerably enhance memory and concentration, sleep quality, and psychological well-being in general. There was also a noticeable decrease in stress levels. It seems that the medication was both safe and well-tolerated²⁶.

6. Antiparkinson activity of Withania somnifera:

Parkinson’s disease (PD) has been associated with both mitochondrial dysfunction and oxidative stress. Dopaminergic neurons, cholinergic receptors, and several other structures linked to dementia are impacted by oxidative stress, which also leads to mitochondrial dysfunction and neuroinflammation. Increased levels of the big protein Leucine-Rich Repeat Kinase 2 (LRRK2), also known as dardarin, are linked to neuronal toxicity in people with familial PD. The chaperone heat shock protein 90 (Hsp90) and its co-chaperone Cdc37 work together to stabilise it²⁷. Withaferin-A treatment on the microglial cell line N9 decreased LRRK2 levels in cells in a concentration and time-dependent way. This disruption of the Hsp90, Cdc37, and LRRK2 relationship caused LRRK2 to become unstable and downregulated. Additionally, the Hsp90-Cdc37 complex inhibitor celastrol decreased LRRK2 levels while Withaferin-A improved LRRK2 clearance when celastrol was present. To simulate PD symptoms in animal models, 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and 6-hydroxydopamine are utilised. By scavenging free radicals and shielding the dopaminergic neurons, oral administration of W. somnifera ethanolic root extract at a dose of 300 mg/kg/day improved gripping ability, motor movements, and dopamine levels in the striatum of male Wistar rats in the 6-hydroxy dopamine-induced model as well as maneb and paraquat models. Antioxidant enzymes like glutathione reductase, catalase, and glutathione peroxidase levels were up, but oxidative stress indicators like lipid peroxidation and nitrite levels were lowered. Similarly, Prakash et al. (2014) showed that ethanolic root extract of W. somnifera at a dose of 100 mg/kg for 9 weeks provided nigrostriatal dopaminergic neuroprotection against maneb and paraquat-induced Parkinsonism via modulation of oxidative stress. They also showed significant improvements in canonical PD indicators, such as impaired locomotor activity, improved pro-apoptotic state via reducing Bax.

Although the origin is unknown, it is believed that the fact that oestrogen has a protective role in the body may explain why the condition affects men slightly more frequently than women²⁸.

CONCLUSION:

For many years, traditional medical systems have utilised Withania somnifera, a plant substance, especially in Ayurvedic medicine. Research on the many benefits of Withania somnifera on various physiological systems has been done throughout the years, and the results have demonstrated the plant's many positive impacts. It's crucial to remember that Withania somnifera research is still in its early stages and that additional studies will be required to confirm any potential therapeutic benefits as well as to establish the best dosages and usage times. The safety of Withania somnifera should also be considered, especially when taking it with other drugs or supplements. Thus, more study is required to shed light on the possible advantages and disadvantages of utilising Withania somnifera as a medicinal drug, especially clinical trials. It is evident from the study done thus far that Withania somnifera root is a plant raw material with multifaceted benefits. However, because so many new studies are being published, it is imperative that the knowledge about this raw material be updated on a regular basis, both in terms of its potential for use in the treatment of diseases and, most importantly, in terms of its safe use. Furthermore, more research is needed to determine the effects of Withania somnifera, namely in the clinical domain to verify the effectiveness of the herb. According to the research, Withania somnifera may be useful as a medication, particularly for a variety of neurological conditions. The potential therapeutic applications of Withania somnifera are supported by data, although the exact processes via which it works are still unclear. To create more specialised and efficient treatment plans, it's critical to identify the exact mechanisms of action of Withania somnifera.

REFERENCES:

1. Mandlik (Ingawale), Deepa S.; Namdeo, Ajay G. (2020). Pharmacological evaluation of Withania somnifera highlighting its healthcare claims, safety, and toxicity aspects. Journal of Dietary Supplements.

2. Monograph (2004) Withania somnifera. Altern. Med. Rev., 9, 211–214.

3. Tandon, N. & Yadav, S. S. (2020) Safety and clinical effectiveness of Withania somnifera (Linn.) Dunal root in human ailments. J. Ethnopharmacol., 255, 112 768.

4. Dar, N. J., Hamid, A. & Ahmad, M. (2015) Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell. Mol. Life Sci., 72, 4445–4460.

5. Lopresti, Adrian L.PhD, Smith Stephen J. MA, Malvi, Hakeemudin MBBS MD, Kodgule, Rahul MBBS; An investigation into the stress-relieving and pharmacological actions of an Withania somnifera extract A randomized, double-blind, placebo-controlled study.

6. Food data central. Organic Withania somnifera powder, Withania somnifera.

7. Sarma Nittala S, Lavie D. Studies on the 5β,6β-epoxide opening in withanolides. J Chem Soc Perkin 1. Jan. 1982;2835–9.

8. Hassannia B, Logie E, Vandenabeele P, Vanden Berghe T, Vanden Berghe W. Withaferin a: from ayurvedic folk medicine to preclinical anti-cancer drug. Biochem Pharmacol. Mar. 2020;173.

9. Nile SH, Nile A, Gansukh E, Baskar V, Kai G. Subcritical water extraction of withanosides and withanolides from Withania somnifera L and their biological activities. Food Chem Toxicol. Oct. 2019;132.

10. Bravo BJA, Sauvain M, Gimenez TA, Balanza E, Serani L, Laprevote O, et al. Trypanocidal withanolides and withanolide glycosides from Dunalia brachyacantha. J Nat Prod. 2001

11. Schröter HB, Neumann D, Katritzky AR, Swinbourne FJ. Withasomnine. A pyrazole alkaloid from Withania somnifera Dun. Tetrahedron. Jan. 1966

12. Das S, Saraf A, Sharma D, Sohal JK. Qualitative screnning of bioactive secondary metabolites present in Withania somnifera and Rauwolfia serpentina root and stem extract with pharmacological importance. Int J Res Ana Rev. 2019

13. A. Bhattacharya, M. Ramanathan, S. Ghosal, S.K. Bhattacharya. Effect of Withania somnifera glycowithanolides on iron-induced hepatotoxicity in rats. Phytother. Res. 2000; 14(7): 568-570.

14. S.K. Bhattacharya, A. Bhattacharya, K. Sairam, S. Ghosal. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000; 7(6): 463-469.

15. Thakur, D.A.; Dey, A.; Chatterjee, S.; Kumar, V. Reverse Ayurvedic Pharmacology of Withania somnifera as an Adaptogenic Anti-Diabetic Plant: A Pilot Study. Curr. Tradit. Med. 2015; 1: 51–61.

16. Andallu, B.; Radhika, B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J. Exp. Biol. 2000; 38: 607–609.

17. Udayakumar, R.; Kasthurirengan, S., Vasudevan, A., Mariashibu, T.S.; Rayan, J.J.S.; Choi, C.W.; Ganapathi, A.; Kim, S.C. Antioxidant effect of dietary supplement Withania somnifera L. reduce blood glucose levels in alloxan-induced diabetic rats. Plant Foods Hum. Nutr. 2010; 65: 91–98.

18. Kumari, M.; Gupta, R.P. In vitro antibacterial effect of Withania somnifera root extract on Escherichia coli. Vet. World 2015, 8, 57.

19. Singh, G.; Kumar, P. Evaluation of antimicrobial efficacy of flavonoids of Withania somnifera L. Indian J. Pharm. Sci. 2011; 73: 473.

20. Mehta, V.; Chander, H.; Munshi, A. Mechanisms of anti-tumor activity of Withania somnifera. Nutr. Cancer 2021, 73, 914–926.

21. Singh, N.; Yadav, S.S.; Rao, A.S.; Nandal, A.; Kumar, S.; Ganaie, S.A.; Narasihman, B. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal. J. Ethnopharmacol. 2021; 270: 113704.

22. Jawarneh, S.; Talib, W.H. Combination of Withania somnifera Water Extract and Intermittent Fasting as a Therapy to Overcome Cisplatin Resistance in Breast Cancer: An in vitro and in vivo Study. Front. Nutr. 2022; 9: 863619.

23. Fuladi, S.; Emami, S.A.; Mohammadpour, A.H.; Karimani, A.; Manteghi, A.A.; Sahebkar, A. Assessment of the Efficacy of Withania somnifera Root Extract in Patients with Generalized Anxiety Disorder: A Randomized Double-blind Placebo-Controlled Trial. Curr. Rev. Clin. Exp. Pharmacol. 2021; 16: 191–196.

24. Jarząbek-Bielecka, G.; Plagens-Rotman, K.; Kędzia, W.; Religioni, U.; Merks, P. Znaczenie DHEA w zdrowiu seksualnym w okresie przekwitania. Farm. Pol. 2020; 76: 537–540.

25. Lopresti, A.L.; Smith, S.J.; Malvi, H.; Kodgule, R.; Wane, D. An investigation into the stress-relieving and pharmacological actions of an Withania somnifera extract: A randomized, double-blind, placebo-controlled study. Medicine. 2019; 98: e17186.

26. Chengappa, K.N.R.; Brar, J.S.; Gannon, J.M.; Schlicht, P.J. Adjunctive use of a standardized extract of Withania somnifera to treat symptom exacerbation in schizophrenia: A randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry. 2018; 79: 22496.

27. Birla H., Keswani C., Rai S. N., Singh S. S., Zahra W., Dilnashin H., et al. Neuroprotective effects of Withania somnifera in BPA induced-cognitive dysfunction and oxidative stress in mice. Behav. Brain Funct. 2019; 15 (1): 9. 10.1186/s12993-019-0160-4

28. Zając, M.; Jelińska, A.; Muszalska, I.C. Chemia Leków z Elementami Chemii Medycznej dla Studentów Farmacji i Farmaceutów; Uniwersytet Medyczny im74. Karola Marcinkowskiego: Poznan, Poland, 2018.

Received on 07.11.2023 Modified on 19.01.2024

Asian J. Res. Pharm. Sci. 2024; 14(2):159-166.

DOI: 10.52711/2231-5659.2024.00025